Global Diphtheria Tetanus Pertussis Vaccine Market Growth 2026-2032

October 2026 | 91 pages | ID: G589FEE51659EN
LP Information

Abstracts

The global Diphtheria Tetanus Pertussis Vaccine market size is predicted to grow from US$ 5834 million in 2025 to US$ 7454 million in 2032; it is expected to grow at a CAGR of 3.6% from 2026 to 2032.

In 2025, global Diphtheria Tetanus Pertussis Vaccine production reached approximately 373 million doses, with an average global market price of around US$ 16 per dose. The DPT vaccine or Diphtheria Tetanus Pertussis Vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus. In this report, we cover all the DTP-containing vaccines. Gross margin for the Diphtheria Tetanus Pertussis Vaccine in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.

The global Diphtheria Tetanus Pertussis Vaccine market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The Diphtheria Tetanus Pertussis Vaccine industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for Diphtheria Tetanus Pertussis Vaccines is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Diphtheria Tetanus Pertussis Vaccine Industry Forecast” looks at past sales and reviews total world Diphtheria Tetanus Pertussis Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Diphtheria Tetanus Pertussis Vaccine sales for 2026 through 2032. With Diphtheria Tetanus Pertussis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diphtheria Tetanus Pertussis Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Diphtheria Tetanus Pertussis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diphtheria Tetanus Pertussis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diphtheria Tetanus Pertussis Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diphtheria Tetanus Pertussis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diphtheria Tetanus Pertussis Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Diphtheria Tetanus Pertussis Vaccine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

• DTaP
• Tdap
• DTwP

Segmentation by Composition:

• Acellular Vaccines
• Whole-cell Vaccines

Segmentation by User:

• Below 12 Months
• Above 12 Months

Segmentation by Application:

• Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi Pasteur
• GSK
• Serum Institute of India
• KM Biologics
• Wuhan Institute of Biological Products (WIBP)
• Walvax Biotechnology Co., Ltd.
• Chengdu Institute of Biological Products (CDIBP)
• Beijing Minhai Biotechnology Co., Ltd.
• CanSino Biologics Inc.

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Diphtheria Tetanus Pertussis Vaccine market?
• What factors are driving Diphtheria Tetanus Pertussis Vaccine market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Diphtheria Tetanus Pertussis Vaccine market opportunities vary by end market size?
• How does Diphtheria Tetanus Pertussis Vaccine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Diphtheria Tetanus Pertussis Vaccine Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Diphtheria Tetanus Pertussis Vaccine by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Diphtheria Tetanus Pertussis Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Diphtheria Tetanus Pertussis Vaccine Segment by Type
  2.2.1 DTaP
  2.2.2 Tdap
  2.2.3 DTwP
  2.2.4 Diphtheria Tetanus Pertussis Vaccine Sales by Type
    2.2.4.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Type (2021-2026)
2.3 Diphtheria Tetanus Pertussis Vaccine Segment by Composition
  2.3.1 Acellular Vaccines
  2.3.2 Whole-cell Vaccines
  2.3.3 Diphtheria Tetanus Pertussis Vaccine Sales by Composition
    2.3.3.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Composition (2021-2026)
    2.3.3.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue and Market Share by Composition (2021-2026)
    2.3.3.3 Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Composition (2021-2026)
2.4 Diphtheria Tetanus Pertussis Vaccine Segment by User
  2.4.1 Below 12 Months
  2.4.2 Above 12 Months
  2.4.3 Diphtheria Tetanus Pertussis Vaccine Sales by User
    2.4.3.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by User (2021-2026)
    2.4.3.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue and Market Share by User (2021-2026)
    2.4.3.3 Global Diphtheria Tetanus Pertussis Vaccine Sale Price by User (2021-2026)
2.5 Diphtheria Tetanus Pertussis Vaccine Segment by Application
  2.5.1 Hospital
  2.5.2 Clinic
  2.5.3 Diphtheria Tetanus Pertussis Vaccine Sales by Application
    2.5.3.1 Global Diphtheria Tetanus Pertussis Vaccine Sale Market Share by Application (2021-2026)
    2.5.3.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue and Market Share by Application (2021-2026)
    2.5.3.3 Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Diphtheria Tetanus Pertussis Vaccine Breakdown Data by Company
  3.1.1 Global Diphtheria Tetanus Pertussis Vaccine Annual Sales by Company (2021-2026)
  3.1.2 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Diphtheria Tetanus Pertussis Vaccine Annual Revenue by Company (2021-2026)
  3.2.1 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Company (2021-2026)
  3.2.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Company
3.4 Key Manufacturers Diphtheria Tetanus Pertussis Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Diphtheria Tetanus Pertussis Vaccine Product Location Distribution
  3.4.2 Players Diphtheria Tetanus Pertussis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DIPHTHERIA TETANUS PERTUSSIS VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Diphtheria Tetanus Pertussis Vaccine Market Size by Geographic Region (2021-2026)
  4.1.1 Global Diphtheria Tetanus Pertussis Vaccine Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Diphtheria Tetanus Pertussis Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Diphtheria Tetanus Pertussis Vaccine Market Size by Country/Region (2021-2026)
  4.2.1 Global Diphtheria Tetanus Pertussis Vaccine Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Diphtheria Tetanus Pertussis Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Diphtheria Tetanus Pertussis Vaccine Sales Growth
4.4 APAC Diphtheria Tetanus Pertussis Vaccine Sales Growth
4.5 Europe Diphtheria Tetanus Pertussis Vaccine Sales Growth
4.6 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Growth

5 AMERICAS

5.1 Americas Diphtheria Tetanus Pertussis Vaccine Sales by Country
  5.1.1 Americas Diphtheria Tetanus Pertussis Vaccine Sales by Country (2021-2026)
  5.1.2 Americas Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2021-2026)
5.2 Americas Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026)
5.3 Americas Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Diphtheria Tetanus Pertussis Vaccine Sales by Region
  6.1.1 APAC Diphtheria Tetanus Pertussis Vaccine Sales by Region (2021-2026)
  6.1.2 APAC Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2021-2026)
6.2 APAC Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026)
6.3 APAC Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Diphtheria Tetanus Pertussis Vaccine by Country
  7.1.1 Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2021-2026)
  7.1.2 Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2021-2026)
7.2 Europe Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026)
7.3 Europe Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine by Country
  8.1.1 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diphtheria Tetanus Pertussis Vaccine
10.3 Manufacturing Process Analysis of Diphtheria Tetanus Pertussis Vaccine
10.4 Industry Chain Structure of Diphtheria Tetanus Pertussis Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Diphtheria Tetanus Pertussis Vaccine Distributors
11.3 Diphtheria Tetanus Pertussis Vaccine Customer

12 WORLD FORECAST REVIEW FOR DIPHTHERIA TETANUS PERTUSSIS VACCINE BY GEOGRAPHIC REGION

12.1 Global Diphtheria Tetanus Pertussis Vaccine Market Size Forecast by Region
  12.1.1 Global Diphtheria Tetanus Pertussis Vaccine Forecast by Region (2027-2032)
  12.1.2 Global Diphtheria Tetanus Pertussis Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Diphtheria Tetanus Pertussis Vaccine Forecast by Type (2027-2032)
12.7 Global Diphtheria Tetanus Pertussis Vaccine Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi Pasteur
  13.1.1 Sanofi Pasteur Company Information
  13.1.2 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.1.3 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Sanofi Pasteur Main Business Overview
  13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
  13.2.1 GSK Company Information
  13.2.2 GSK Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.2.3 GSK Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 GSK Main Business Overview
  13.2.5 GSK Latest Developments
13.3 Serum Institute of India
  13.3.1 Serum Institute of India Company Information
  13.3.2 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.3.3 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Serum Institute of India Main Business Overview
  13.3.5 Serum Institute of India Latest Developments
13.4 KM Biologics
  13.4.1 KM Biologics Company Information
  13.4.2 KM Biologics Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.4.3 KM Biologics Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 KM Biologics Main Business Overview
  13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products (WIBP)
  13.5.1 Wuhan Institute of Biological Products (WIBP) Company Information
  13.5.2 Wuhan Institute of Biological Products (WIBP) Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.5.3 Wuhan Institute of Biological Products (WIBP) Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Wuhan Institute of Biological Products (WIBP) Main Business Overview
  13.5.5 Wuhan Institute of Biological Products (WIBP) Latest Developments
13.6 Walvax Biotechnology Co., Ltd.
  13.6.1 Walvax Biotechnology Co., Ltd. Company Information
  13.6.2 Walvax Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.6.3 Walvax Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Walvax Biotechnology Co., Ltd. Main Business Overview
  13.6.5 Walvax Biotechnology Co., Ltd. Latest Developments
13.7 Chengdu Institute of Biological Products (CDIBP)
  13.7.1 Chengdu Institute of Biological Products (CDIBP) Company Information
  13.7.2 Chengdu Institute of Biological Products (CDIBP) Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.7.3 Chengdu Institute of Biological Products (CDIBP) Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Chengdu Institute of Biological Products (CDIBP) Main Business Overview
  13.7.5 Chengdu Institute of Biological Products (CDIBP) Latest Developments
13.8 Beijing Minhai Biotechnology Co., Ltd.
  13.8.1 Beijing Minhai Biotechnology Co., Ltd. Company Information
  13.8.2 Beijing Minhai Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.8.3 Beijing Minhai Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Beijing Minhai Biotechnology Co., Ltd. Main Business Overview
  13.8.5 Beijing Minhai Biotechnology Co., Ltd. Latest Developments
13.9 CanSino Biologics Inc.
  13.9.1 CanSino Biologics Inc. Company Information
  13.9.2 CanSino Biologics Inc. Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
  13.9.3 CanSino Biologics Inc. Diphtheria Tetanus Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 CanSino Biologics Inc. Main Business Overview
  13.9.5 CanSino Biologics Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Diphtheria Tetanus Pertussis Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Diphtheria Tetanus Pertussis Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DTaP
Table 4. Major Players of Tdap
Table 5. Major Players of DTwP
Table 6. Global Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026) & (K Dose)
Table 7. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Acellular Vaccines
Table 12. Major Players of Whole-cell Vaccines
Table 13. Global Diphtheria Tetanus Pertussis Vaccine Sales by Composition (2021-2026) & (K Dose)
Table 14. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Composition (2021-2026)
Table 15. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Composition (2021-2026) & ($ million)
Table 16. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Composition (2021-2026)
Table 17. Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Composition (2021-2026) & (US$/Dose)
Table 18. Major Players of Below 12 Months
Table 19. Major Players of Above 12 Months
Table 20. Global Diphtheria Tetanus Pertussis Vaccine Sales by User (2021-2026) & (K Dose)
Table 21. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by User (2021-2026)
Table 22. Global Diphtheria Tetanus Pertussis Vaccine Revenue by User (2021-2026) & ($ million)
Table 23. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by User (2021-2026)
Table 24. Global Diphtheria Tetanus Pertussis Vaccine Sale Price by User (2021-2026) & (US$/Dose)
Table 25. Global Diphtheria Tetanus Pertussis Vaccine Sale by Application (2021-2026) & (K Dose)
Table 26. Global Diphtheria Tetanus Pertussis Vaccine Sale Market Share by Application (2021-2026)
Table 27. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2021-2026) & ($ million)
Table 28. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application (2021-2026)
Table 29. Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 30. Global Diphtheria Tetanus Pertussis Vaccine Sales by Company (2021-2026) & (K Dose)
Table 31. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Company (2021-2026)
Table 32. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Company (2021-2026)
Table 34. Global Diphtheria Tetanus Pertussis Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 35. Key Manufacturers Diphtheria Tetanus Pertussis Vaccine Producing Area Distribution and Sales Area
Table 36. Players Diphtheria Tetanus Pertussis Vaccine Products Offered
Table 37. Diphtheria Tetanus Pertussis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Diphtheria Tetanus Pertussis Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 41. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share Geographic Region (2021-2026)
Table 42. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Diphtheria Tetanus Pertussis Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 45. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country/Region (2021-2026)
Table 46. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Diphtheria Tetanus Pertussis Vaccine Sales by Country (2021-2026) & (K Dose)
Table 49. Americas Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2021-2026)
Table 50. Americas Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026) & (K Dose)
Table 52. Americas Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026) & (K Dose)
Table 53. APAC Diphtheria Tetanus Pertussis Vaccine Sales by Region (2021-2026) & (K Dose)
Table 54. APAC Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2021-2026)
Table 55. APAC Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026) & (K Dose)
Table 57. APAC Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026) & (K Dose)
Table 58. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2021-2026) & (K Dose)
Table 59. Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026) & (K Dose)
Table 61. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026) & (K Dose)
Table 62. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Country (2021-2026) & (K Dose)
Table 63. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Type (2021-2026) & (K Dose)
Table 65. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Application (2021-2026) & (K Dose)
Table 66. Key Market Drivers & Growth Opportunities of Diphtheria Tetanus Pertussis Vaccine
Table 67. Key Market Challenges & Risks of Diphtheria Tetanus Pertussis Vaccine
Table 68. Key Industry Trends of Diphtheria Tetanus Pertussis Vaccine
Table 69. Diphtheria Tetanus Pertussis Vaccine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Diphtheria Tetanus Pertussis Vaccine Distributors List
Table 72. Diphtheria Tetanus Pertussis Vaccine Customer List
Table 73. Global Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 74. Global Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 76. Americas Diphtheria Tetanus Pertussis Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 78. APAC Diphtheria Tetanus Pertussis Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 80. Europe Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 82. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 84. Global Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 86. Global Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Sanofi Pasteur Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 89. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Sanofi Pasteur Main Business
Table 91. Sanofi Pasteur Latest Developments
Table 92. GSK Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 94. GSK Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Serum Institute of India Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 99. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Serum Institute of India Main Business
Table 101. Serum Institute of India Latest Developments
Table 102. KM Biologics Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 104. KM Biologics Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. Wuhan Institute of Biological Products (WIBP) Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Wuhan Institute of Biological Products (WIBP) Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 109. Wuhan Institute of Biological Products (WIBP) Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Wuhan Institute of Biological Products (WIBP) Main Business
Table 111. Wuhan Institute of Biological Products (WIBP) Latest Developments
Table 112. Walvax Biotechnology Co., Ltd. Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Walvax Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 114. Walvax Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Walvax Biotechnology Co., Ltd. Main Business
Table 116. Walvax Biotechnology Co., Ltd. Latest Developments
Table 117. Chengdu Institute of Biological Products (CDIBP) Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Chengdu Institute of Biological Products (CDIBP) Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 119. Chengdu Institute of Biological Products (CDIBP) Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. Chengdu Institute of Biological Products (CDIBP) Main Business
Table 121. Chengdu Institute of Biological Products (CDIBP) Latest Developments
Table 122. Beijing Minhai Biotechnology Co., Ltd. Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Minhai Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 124. Beijing Minhai Biotechnology Co., Ltd. Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. Beijing Minhai Biotechnology Co., Ltd. Main Business
Table 126. Beijing Minhai Biotechnology Co., Ltd. Latest Developments
Table 127. CanSino Biologics Inc. Basic Information, Diphtheria Tetanus Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. CanSino Biologics Inc. Diphtheria Tetanus Pertussis Vaccine Product Portfolios and Specifications
Table 129. CanSino Biologics Inc. Diphtheria Tetanus Pertussis Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 130. CanSino Biologics Inc. Main Business
Table 131. CanSino Biologics Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Diphtheria Tetanus Pertussis Vaccine
Figure 2. Diphtheria Tetanus Pertussis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diphtheria Tetanus Pertussis Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Diphtheria Tetanus Pertussis Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of DTaP
Figure 12. Product Picture of Tdap
Figure 13. Product Picture of DTwP
Figure 14. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type in 2026
Figure 15. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Acellular Vaccines
Figure 17. Product Picture of Whole-cell Vaccines
Figure 18. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Composition in 2026
Figure 19. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Composition (2021-2026)
Figure 20. Product Picture of Below 12 Months
Figure 21. Product Picture of Above 12 Months
Figure 22. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by User in 2026
Figure 23. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by User (2021-2026)
Figure 24. Diphtheria Tetanus Pertussis Vaccine Consumed in Hospital
Figure 25. Global Diphtheria Tetanus Pertussis Vaccine Market: Hospital (2021-2026) & (K Dose)
Figure 26. Diphtheria Tetanus Pertussis Vaccine Consumed in Clinic
Figure 27. Global Diphtheria Tetanus Pertussis Vaccine Market: Clinic (2021-2026) & (K Dose)
Figure 28. Global Diphtheria Tetanus Pertussis Vaccine Sale Market Share by Application (2025)
Figure 29. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application in 2025
Figure 30. Diphtheria Tetanus Pertussis Vaccine Sales by Company in 2025 (K Dose)
Figure 31. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Company in 2025
Figure 32. Diphtheria Tetanus Pertussis Vaccine Revenue by Company in 2025 ($ millions)
Figure 33. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Company in 2025
Figure 34. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Diphtheria Tetanus Pertussis Vaccine Sales 2021-2026 (K Dose)
Figure 37. Americas Diphtheria Tetanus Pertussis Vaccine Revenue 2021-2026 ($ millions)
Figure 38. APAC Diphtheria Tetanus Pertussis Vaccine Sales 2021-2026 (K Dose)
Figure 39. APAC Diphtheria Tetanus Pertussis Vaccine Revenue 2021-2026 ($ millions)
Figure 40. Europe Diphtheria Tetanus Pertussis Vaccine Sales 2021-2026 (K Dose)
Figure 41. Europe Diphtheria Tetanus Pertussis Vaccine Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales 2021-2026 (K Dose)
Figure 43. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue 2021-2026 ($ millions)
Figure 44. Americas Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country in 2025
Figure 45. Americas Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2021-2026)
Figure 46. Americas Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2021-2026)
Figure 47. Americas Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2021-2026)
Figure 48. United States Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region in 2025
Figure 53. APAC Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2021-2026)
Figure 54. APAC Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2021-2026)
Figure 55. APAC Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2021-2026)
Figure 56. China Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. India Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country in 2025
Figure 64. Europe Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2021-2026)
Figure 65. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2021-2026)
Figure 66. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2021-2026)
Figure 67. Germany Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. France Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2021-2026)
Figure 75. Egypt Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Diphtheria Tetanus Pertussis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Diphtheria Tetanus Pertussis Vaccine in 2026
Figure 81. Manufacturing Process Analysis of Diphtheria Tetanus Pertussis Vaccine
Figure 82. Industry Chain Structure of Diphtheria Tetanus Pertussis Vaccine
Figure 83. Channels of Distribution
Figure 84. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Forecast by Region (2027-2032)
Figure 85. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share Forecast by Application (2027-2032)